EP0646173A4 - Reactif pour dosages d'agglutination. - Google Patents

Reactif pour dosages d'agglutination.

Info

Publication number
EP0646173A4
EP0646173A4 EP93909677A EP93909677A EP0646173A4 EP 0646173 A4 EP0646173 A4 EP 0646173A4 EP 93909677 A EP93909677 A EP 93909677A EP 93909677 A EP93909677 A EP 93909677A EP 0646173 A4 EP0646173 A4 EP 0646173A4
Authority
EP
European Patent Office
Prior art keywords
reagent
agglutination assays
agglutination
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93909677A
Other languages
German (de)
English (en)
Other versions
EP0646173A1 (fr
Inventor
Glenn George Lilley
Peter John Hudson
Carmel Judith Hillyard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agen Ltd
Original Assignee
Agen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agen Ltd filed Critical Agen Ltd
Publication of EP0646173A1 publication Critical patent/EP0646173A1/fr
Publication of EP0646173A4 publication Critical patent/EP0646173A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP93909677A 1992-05-22 1993-05-19 Reactif pour dosages d'agglutination. Withdrawn EP0646173A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPL255192 1992-05-22
AUPL2551/92 1992-05-22
PCT/AU1993/000228 WO1993024630A1 (fr) 1992-05-22 1993-05-19 Reactif pour dosages d'agglutination

Publications (2)

Publication Number Publication Date
EP0646173A1 EP0646173A1 (fr) 1995-04-05
EP0646173A4 true EP0646173A4 (fr) 1997-02-26

Family

ID=3776178

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93909677A Withdrawn EP0646173A4 (fr) 1992-05-22 1993-05-19 Reactif pour dosages d'agglutination.

Country Status (4)

Country Link
EP (1) EP0646173A4 (fr)
JP (1) JPH07506727A (fr)
WO (1) WO1993024630A1 (fr)
ZA (1) ZA933552B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226065D0 (en) * 1992-12-14 1993-02-10 Ici Plc Peptides
RU95109861A (ru) * 1994-06-09 1997-06-10 Сентро Де Инженьериа Генетика И Биотекнологиа (Cu) Рекомбинантный фрагмент антитела, применение scfv, применение фрагмента антитела или пептида, способ получения scfv
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
US5929304A (en) * 1995-09-14 1999-07-27 Croptech Development Corporation Production of lysosomal enzymes in plant-based expression systems
US5994308A (en) * 1996-02-28 1999-11-30 Board Of Trustees Of Southern Illinois University Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use
CU22737A1 (es) * 1997-04-28 2002-02-28 Ct Ingenieria Genetica Biotech Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico
JP5426881B2 (ja) 2005-11-12 2014-02-26 プラットフォーム・ダイアグノスティクス・リミテッド 凝集アッセイ
EP2041175A4 (fr) * 2006-06-23 2011-03-16 Augmenta Biolog Llc Conjugues immunitaires cibles
MX347154B (es) 2012-02-24 2017-02-21 Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
US20200247903A1 (en) * 2017-10-20 2020-08-06 Csl Ltd. Method
CN117801111B (zh) * 2024-03-01 2024-05-28 北京纳百生物科技有限公司 一种结合犬红细胞的特异性抗体及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131424A2 (fr) * 1983-07-08 1985-01-16 National Research Development Corporation Préparations d'anticorps
WO1988005913A1 (fr) * 1987-01-29 1988-08-11 Cytosignet, Inc. Detection d'un analyte dans des echantillons contenant des particules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4894347A (en) * 1987-09-17 1990-01-16 Agen Limited Erythrocyte agglutination assay
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
ATE144793T1 (de) * 1989-06-29 1996-11-15 Medarex Inc Bispezifische reagenzien für die aids-therapie
CA2066736A1 (fr) * 1989-09-25 1991-03-26 Carmel Judith Hillyard Essai d'agglutination
AU656181B2 (en) * 1991-05-03 1995-01-27 Pasteur Sanofi Diagnostics Heterobifunctional antibodies possessing dual catalytic and specific antigen binding properties and methods using them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131424A2 (fr) * 1983-07-08 1985-01-16 National Research Development Corporation Préparations d'anticorps
WO1988005913A1 (fr) * 1987-01-29 1988-08-11 Cytosignet, Inc. Detection d'un analyte dans des echantillons contenant des particules

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HILLYARD C. J. ET AL.,: "Disease diagnosis in two minutes", TODAY'S LIFE SCIENCE, vol. 3, - 1991, pages 52 - 60, XP000615338 *
KEMP B. E. ET AL.,: "Autologous red cell agglutination assay for hiv-1 antibodies: simplified test whole blood", SCIENCE, vol. 241, no. 4871, 9 September 1988 (1988-09-09), pages 1352 - 1354, XP000615341 *
See also references of WO9324630A1 *

Also Published As

Publication number Publication date
EP0646173A1 (fr) 1995-04-05
WO1993024630A1 (fr) 1993-12-09
JPH07506727A (ja) 1995-07-27
ZA933552B (en) 1993-12-09

Similar Documents

Publication Publication Date Title
DE59207914D1 (de) Verschluss für Reagenzbehälter
EP0627932A4 (fr) Nouvelle structure d'anticorps.
EP0617281A3 (fr) Réactif pour la mesure de leucocytes immatures.
AU7440394A (en) Reagent for endotoxin-specific assay
AU4733993A (en) Reagent for endotoxin-specific assay
GB9014903D0 (en) Assays
EP0795131A4 (fr) Systeme d'essai d'agglutination de particules
AU4757796A (en) Electrochemiluminescence assays for endotoxins
EP0593956A3 (fr) Essai d'agglutination utilisant un ligand multivalent.
EP0646173A4 (fr) Reactif pour dosages d'agglutination.
IL100841A0 (en) Immunoassay
EP0507587A3 (en) Immunoassay for immunoglubulins
AU4703889A (en) Improved dipstick device for assays
EP0670494A3 (fr) Essai immunologique d'anticorps anti-tréponèmes.
AU1462992A (en) Agglutination assay
EP0719345A4 (fr) Reactif
PH30946A (en) Agglutination assay.
GB2250026B (en) Assays using albumin-tetrazolium interaction
EP0666323A4 (fr) Reactif pour l'analyse du glucose.
EP0248621A3 (en) Reagent for immunoassay
SG63596A1 (en) Receptor function assays
EP0420170A3 (en) Stabilizing reagent for membrane immunoassay
GB9107983D0 (en) Assays
EP0629857A3 (fr) Immunoessai pour la determination quantitative d'antigènes.
GB8721276D0 (en) Immunoassay reagents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19941128

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE FR GB IT LI

17Q First examination report despatched

Effective date: 19990616

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000406